| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 175,9 k € | -13.2% | 202,5 k € | +33.6% | 151,6 k € | -30.7% | 218,9 k € | +20.2% | 182,2 k € | -7.4% | 196,8 k € | +2.5% | 192,0 k € | +1717.1% | 10,6 k € | -74.2% | 41,0 k € | -51.5% | 84,6 k € | -20.9% | 106,9 k € | -15.0% | 125,8 k € | -24.7% | 167,1 k € | +9.9% | 152,1 k € | +37.8% | 110,3 k € | +363.1% | 23,8 k € | |
| EBITDA | 97,9 k € | -18.5% | 120,2 k € | +18.9% | 101,1 k € | -27.7% | 139,9 k € | +1328.8% | 9,8 k € | +575.3% | 1,4 k € | -97.1% | 49,8 k € | +798.2% | -7,1 k € | -126.8% | 26,6 k € | -58.5% | 64,2 k € | +25.4% | 51,2 k € | -67.9% | 159,5 k € | +73.3% | 92,0 k € | -19.4% | 114,1 k € | +17.5% | 97,1 k € | +321.5% | 23,1 k € | |
| Operating profit | 91,8 k € | -19.8% | 114,4 k € | +14.2% | 100,2 k € | -27.6% | 138,4 k € | +1575.4% | 8,3 k € | +1387.9% | -641,2 € | -101.8% | 35,7 k € | +212.7% | -31,7 k € | -1009.1% | 3,5 k € | -91.1% | 39,2 k € | +63.1% | 24,1 k € | -81.4% | 129,5 k € | +112.7% | 60,9 k € | -29.0% | 85,8 k € | +23.5% | 69,5 k € | +2831.1% | -2,5 k € | |
| Profit/loss | 63,9 k € | -9.5% | 70,7 k € | +57.4% | 44,9 k € | -44.8% | 81,4 k € | +4017.5% | -2,1 k € | +63.3% | -5,7 k € | -122.1% | 25,6 k € | +1104.3% | -2,6 k € | -114.0% | 18,3 k € | -44.6% | 33,0 k € | +39.1% | 23,7 k € | +107.0% | 11,5 k € | -35.3% | 17,7 k € | -56.2% | 40,4 k € | +11.9% | 36,1 k € | +863.1% | -4,7 k € | |
| Equity | 470,7 k € | +15.7% | 406,8 k € | +21.0% | 336,1 k € | +15.4% | 291,2 k € | +38.8% | 209,9 k € | -1.0% | 212,0 k € | -2.6% | 217,6 k € | +13.3% | 192,0 k € | -1.3% | 194,6 k € | +10.4% | 176,3 k € | +23.0% | 143,3 k € | +33.7% | 107,2 k € | +12.0% | 95,7 k € | +22.7% | 78,0 k € | +107.5% | 37,6 k € | +2463.0% | 1,5 k € | |
| Total assets | 752,7 k € | +14.4% | 657,9 k € | +15.2% | 571,1 k € | +11.4% | 512,8 k € | +26.6% | 404,9 k € | +3.2% | 392,4 k € | -5.9% | 416,9 k € | -27.1% | 571,9 k € | -3.4% | 591,9 k € | -3.5% | 613,3 k € | +9.5% | 560,0 k € | +9.5% | 511,4 k € | -3.4% | 529,3 k € | +13.1% | 468,1 k € | +14.3% | 409,5 k € | +22.1% | 335,3 k € | |
| Cash | 1,6 k € | +4414.2% | 34,9 € | -99.9% | 34,6 k € | +2980.8% | 1,1 k € | +18.1% | 951,0 € | -84.6% | 6,2 k € | +42707.1% | 14,4 € | -99.8% | 6,7 k € | +564.8% | 1,0 k € | +1293.6% | 72,5 € | — | 284,3 € | — | — | — | — | |||||||
| Debts | 281,9 k € | +12.3% | 251,1 k € | +6.9% | 235,0 k € | +6.1% | 221,5 k € | +13.9% | 194,6 k € | +12.8% | 172,4 k € | -13.4% | 199,2 k € | -47.6% | 379,9 k € | -4.4% | 397,4 k € | -9.1% | 437,0 k € | +4.9% | 416,7 k € | +3.2% | 403,8 k € | +5.4% | 383,1 k € | -1.8% | 390,1 k € | +4.9% | 371,9 k € | +11.4% | 333,8 k € | |
| Staff | — | — | 2,5 | — | — | — | — | — | — | — | 0,3 | — | 0,5 | 0,8 | 0,4 | — | ||||||||||||||||
Private limited company · Zaventem · incorporated on 18/12/2008
Private limited company profitable and well capitalised. Cash position rising (+4414.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
EURO SOINS is a Private limited company incorporated in 2008. Its main activity is: Other human health activities. Its registered office is in Zaventem.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette